Business Description
Kyongbo Pharmaceutical Co Ltd
ISIN : KR7214390007
Compare
Compare
Traded in other countries / regions
214390.Korea IPO Date
2015-06-29Description
Kyongbo Pharmaceutical Co Ltd is a pharmaceutical company. It is involved in the business of manufacturing and sales of active pharmaceutical ingredient and finished drugs. Its products include Atorvastatin Calcium Hydrate, S-amlodipine Beslyate, Aripiprazole, Gaskhan and Kyongbo.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 3.73 | |||||
| Interest Coverage | 2.25 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.4 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.1 | |||||
| 3-Year EBITDA Growth Rate | -14.9 | |||||
| 3-Year EPS without NRI Growth Rate | 3.3 | |||||
| 3-Year Book Growth Rate | -2.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.38 | |||||
| 9-Day RSI | 51.78 | |||||
| 14-Day RSI | 50.91 | |||||
| 6-1 Month Momentum % | -2.36 | |||||
| 12-1 Month Momentum % | 11.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 155.49 | |||||
| Days Sales Outstanding | 80.65 | |||||
| Days Payable | 44.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -20.6 | |||||
| Shareholder Yield % | -8.03 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.66 | |||||
| Operating Margin % | 3.94 | |||||
| Net Margin % | 2.32 | |||||
| FCF Margin % | -4.42 | |||||
| ROE % | 3.75 | |||||
| ROA % | 2.07 | |||||
| ROIC % | 4.42 | |||||
| ROC (Joel Greenblatt) % | 5.12 | |||||
| ROCE % | 6.25 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 33.21 | |||||
| PE Ratio without NRI | 33.21 | |||||
| Shiller PE Ratio | 18.17 | |||||
| PS Ratio | 0.77 | |||||
| PB Ratio | 1.23 | |||||
| Price-to-Tangible-Book | 1.26 | |||||
| EV-to-EBIT | 27.48 | |||||
| EV-to-EBITDA | 11.93 | |||||
| EV-to-Revenue | 1.09 | |||||
| EV-to-FCF | -24.61 | |||||
| Price-to-Projected-FCF | 1.85 | |||||
| Price-to-Graham-Number | 1.36 | |||||
| Price-to-Net-Current-Asset-Value | 11.51 | |||||
| Earnings Yield (Greenblatt) % | 3.64 | |||||
| FCF Yield % | -5.74 | |||||
| Forward Rate of Return (Yacktman) % | -6.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kyongbo Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 231,004.101 | ||
| EPS (TTM) (â‚©) | 224 | ||
| Beta | 0.95 | ||
| Volatility % | 48.13 | ||
| 14-Day RSI | 50.91 | ||
| 14-Day ATR (â‚©) | 1.031172 | ||
| 20-Day SMA (â‚©) | 7440 | ||
| 12-1 Month Momentum % | 11.71 | ||
| 52-Week Range (â‚©) | 6060 - 10950 | ||
| Shares Outstanding (Mil) | 23.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kyongbo Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kyongbo Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kyongbo Pharmaceutical Co Ltd Frequently Asked Questions
What is Kyongbo Pharmaceutical Co Ltd(XKRX:214390)'s stock price today?
The current price of XKRX:214390 is â‚©7440.00. The 52 week high of XKRX:214390 is â‚©10950.00 and 52 week low is â‚©6060.00.
When is next earnings date of Kyongbo Pharmaceutical Co Ltd(XKRX:214390)?
The next earnings date of Kyongbo Pharmaceutical Co Ltd(XKRX:214390) is .
Does Kyongbo Pharmaceutical Co Ltd(XKRX:214390) pay dividends? If so, how much?
Kyongbo Pharmaceutical Co Ltd(XKRX:214390) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers